Structure at 2.5-A resolution of chemically synthesized human immunodeficiency virus type 1 protease complexed with a hydroxyethylene-based inhibitor.

作者: Mariusz Jaskolski , Alfredo G. Tomasselli , Tomi K. Sawyer , Douglas G. Staples , Robert L. Heinrikson

DOI: 10.1021/BI00220A023

关键词:

摘要: The crystal structure of a complex between chemically synthesized human immunodeficiency virus type 1 (HIV-1) protease and an octapeptide inhibitor has been refined to R factor 0.138 at 2.5-A resolution. substrate-based inhibitor, H-Val-Ser-Gln-Asn-Leu psi [CH(OH)CH2]Val-Ile-Val-OH (U-85548e) contains hydroxyethylene isostere replacement the scissile bond that is believed mimic tetrahedral transition state proteolytic reaction. This potent Ki less than nM was developed as active-site titrant HIV-1 protease. binds in extended conformation involved beta-sheet interactions with floor flaps enzyme, which form substrate/inhibitor cavity. diastereomer S configuration chiral carbon atom insert, hydroxyl group within H-bonding distance two carboxyl groups enzyme dimer. subunits are related by pseudodyad, superposes them 178 degrees rotation. main difference beta turns flaps, have different conformations monomers. clear preferred orientation active site alternative conformation, if any, minor one (occupancy 30%). A new model enzymatic mechanism proposed reaction viewed one-step process during nucleophile (water molecule) electrophile (an acidic proton) attack concerted manner.

参考文章(36)
G.N. Ramachandran, V. Sasisekharan, Conformation of Polypeptides and Proteins Advances in Protein Chemistry. ,vol. 23, pp. 283- 438 ,(1968) , 10.1016/S0065-3233(08)60402-7
William P. Jencks, Catalysis in chemistry and enzymology ,(1969)
Wayne A. Hendrickson, Stereochemically restrained refinement of macromolecular structures. Methods in Enzymology. ,vol. 115, pp. 252- 270 ,(1985) , 10.1016/0076-6879(85)15021-4
P.M. Fitzgerald, B.M. McKeever, J.F. VanMiddlesworth, J.P. Springer, J.C. Heimbach, C.T. Leu, W.K. Herber, R.A. Dixon, P.L. Darke, Crystallographic analysis of a complex between human immunodeficiency virus type 1 protease and acetyl-pepstatin at 2.0-A resolution. Journal of Biological Chemistry. ,vol. 265, pp. 14209- 14219 ,(1990) , 10.1016/S0021-9258(18)77288-8
Noel A Roberts, Joseph A Martin, Derek Kinchington, Anne V Broadhurst, J Charles Craig, Ian B Duncan, Sarah A Galpin, Balraj K Handa, John Kay, Antonin Kröhn, Robert W Lambert, John H Merrett, John S Mills, Kevin EB Parkes, Sally Redshaw, Alison J Ritchie, Debra L Taylor, Gareth J Thomas, Peter J Machin, Rational design of peptide-based HIV proteinase inhibitors Science. ,vol. 248, pp. 358- 361 ,(1990) , 10.1126/SCIENCE.2183354
Tomi K. Sawyer, Donald T. Pals, Boryeu Mao, Douglas J. Staples, Anne E. DeVaux, Linda L. Maggiora, Joseph A. Affholter, Warren Kati, David Duchamp, Design, structure-activity, and molecular modeling studies of potent renin inhibitory peptides having N-terminal Nin-For-Trp (Ftr): angiotensinogen congeners modified by P1-P1' Phe-Phe, Sta, Leu psi[CH(OH)CH2]Val or leu psi[CH2NH]Val substitutions. Journal of Medicinal Chemistry. ,vol. 31, pp. 18- 30 ,(1988) , 10.1021/JM00396A006
N. E. Kohl, E. A. Emini, W. A. Schleif, L. J. Davis, J. C. Heimbach, R. A. Dixon, E. M. Scolnick, I. S. Sigal, Active human immunodeficiency virus protease is required for viral infectivity. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 85, pp. 4686- 4690 ,(1988) , 10.1073/PNAS.85.13.4686
Jeffrey J. Blumenstein, Terry D. Copeland, Stephen Oroszlan, Christopher J. Michejda, Synthetic non-peptide inhibitors of HIV protease Biochemical and Biophysical Research Communications. ,vol. 163, pp. 980- 987 ,(1989) , 10.1016/0006-291X(89)92318-8
Maria Miller, Mariusz Jaskólski, J. K. Mohana Rao, Jonathan Leis, Alexander Wlodawer, Crystal structure of a retroviral protease proves relationship to aspartic protease family. Nature. ,vol. 337, pp. 576- 579 ,(1989) , 10.1038/337576A0